LUMO

NASDAQ

Lumos Pharma Inc.

SectorHealth CareIndustryBiotechnology: Pharmaceutical PreparationsIPO2011

$4.35+0.01 (+0.35%)

News25/Ratings2

Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone stimulating small molecule, which is in Phase 2b clinical trial for the treatment of pediatric growth hormone deficiency. The company was founded in 2011 and is headquartered in Austin, Texas.

Latest news

25 items

379dPR
Aviceda Therapeutics Appoints Ophthalmology Innovator and Industry Leader Dr. Emmett T. Cunningham, Jr. to Board of Directors
Aviceda Therapeutics ("Aviceda"), a private, clinical-stage biotech company focused on developing next-generation immunomodulators incorporating its proprietary High Affinity Ligands of Siglecs (HALOS™) nanotechnology platform with an aim to alleviate chronic, non-resolving inflammation, today announced the appointment of Emmett T. Cunningham Jr., M.D., Ph.D., M.P.H. to its Board of Directors. Dr. Cunningham brings more than two decades of experience as a physician-scientist, healthcare entrepreneur, and investor. He was previously a Senior Managing Director at the Blackstone Group following its acquisition of Clarus Ventures, where he was a Managing Director. Throughout his investment car
486dSEC
SEC Form 15-12G filed by Lumos Pharma Inc.
15-12G - LUMOS PHARMA, INC. (0001126234) (Filer)
496dINSIDER
Chief Executive Officer Hawkins Richard J returned 757,562 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Director Zoth Lota S. returned 2,187 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Chief Scientific Officer Mckew John C. returned 13,153 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Director Johnson Chad Allen returned 1,076 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Director Van Es-Johansson An returned 1,100 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Director Raffin Thomas A. returned 9,406 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Chief Medical Officer Pitukcheewanont Pisit Duke returned 16,836 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Director Lalande Kevin M. returned 731,522 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Chief Business Officer Schuchart Aaron returned 8,179 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
General Counsel Powers Bradley J returned 6,334 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Director Mccracken Joseph S returned 15,721 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dINSIDER
Chief Financial Officer Lawley Lori D returned 12,284 shares to the company, closing all direct ownership in the company (SEC Form 4)
4 - LUMOS PHARMA, INC. (0001126234) (Issuer)
496dSEC
SEC Form AW filed by Lumos Pharma Inc.
AW - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form EFFECT filed by Lumos Pharma Inc.
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form EFFECT filed by Lumos Pharma Inc.
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form EFFECT filed by Lumos Pharma Inc.
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form EFFECT filed by Lumos Pharma Inc.
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form EFFECT filed by Lumos Pharma Inc.
EFFECT - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form POS AM filed by Lumos Pharma Inc.
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form POS AM filed by Lumos Pharma Inc.
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form POS AM filed by Lumos Pharma Inc.
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form POS AM filed by Lumos Pharma Inc.
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)
497dSEC
SEC Form POS AM filed by Lumos Pharma Inc.
POS AM - LUMOS PHARMA, INC. (0001126234) (Filer)